UroGen Pharma Ltd. (URGN) slipped -5.62% or -2.6 to $43.7. It is nearly 35185 shares traded, which is 49.86% compare to the average total volume 70564. The market cap of URGN is $676.21 million. The year to date change is 14.21%. The 52 week price range is from $17.1 to $69.57. Price of URGN have changed 1.31% during last week. It have changed -3.00% over last month, -24.91% over last 3 months, -6.62% over last 6 months and 151.36% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for URGN is 50.56. It is 15.70% above current price. The 200-day Moving Averages for URGN is 49.38. It is 13.00% above current price. The 52-week High is 69.57. It is 59.20% from the current price. The 52-week Low is 17.1. It is -60.87% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of URGN is 3.28 on 2018-07-31. Short % to float is 1.60%. There are some statistics of URGN. It is has market cap $676.21 million. The share outstanding is 15.47 million. The average volume is 70564. The revenue is 7.81M. The gross profit is 7.52M. The percent of top 15 Institution holding is 58.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of URGN is -24.37%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of URGN is -23.33%.